Literature DB >> 20603078

The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.

Elisa Bergamin1, Peter T Hallock, Steven J Burden, Stevan R Hubbard.   

Abstract

Formation of the vertebrate neuromuscular junction requires, among others proteins, Agrin, a neuronally derived ligand, and the following muscle proteins: LRP4, the receptor for Agrin; MuSK, a receptor tyrosine kinase (RTK); and Dok7 (or Dok-7), a cytoplasmic adaptor protein. Dok7 comprises a pleckstrin-homology (PH) domain, a phosphotyrosine-binding (PTB) domain, and C-terminal sites of tyrosine phosphorylation. Unique among adaptor proteins recruited to RTKs, Dok7 is not only a substrate of MuSK, but also an activator of MuSK's kinase activity. Here, we present the crystal structure of the Dok7 PH-PTB domains in complex with a phosphopeptide representing the Dok7-binding site on MuSK. The structure and biochemical data reveal a dimeric arrangement of Dok7 PH-PTB that facilitates trans-autophosphorylation of the kinase activation loop. The structure provides the molecular basis for MuSK activation by Dok7 and for rationalizing several Dok7 loss-of-function mutations found in patients with congenital myasthenic syndromes. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20603078      PMCID: PMC2917201          DOI: 10.1016/j.molcel.2010.06.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  35 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Building the vertebrate neuromuscular synapse.

Authors:  Steven J Burden
Journal:  J Neurobiol       Date:  2002-12

3.  Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression.

Authors:  M Z Gilman; R N Wilson; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

4.  The in vitro and in vivo phosphotyrosine map of activated MuSK.

Authors:  A Watty; G Neubauer; M Dreger; M Zimmer; M Wilm; S J Burden
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

5.  Congenital myasthenic syndromes and the formation of the neuromuscular junction.

Authors:  David Beeson; Richard Webster; Judith Cossins; Daniel Lashley; Hayley Spearman; Susan Maxwell; Clarke R Slater; John Newsom-Davis; Jacqueline Palace; Angela Vincent
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

6.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

7.  Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor.

Authors:  M J Eck; S Dhe-Paganon; T Trüb; R T Nolte; S E Shoelson
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

9.  Crystal structure of the tyrosine kinase domain of the human insulin receptor.

Authors:  S R Hubbard; L Wei; L Ellis; W A Hendrickson
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

10.  Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations.

Authors:  H Zhou; D J Glass; G D Yancopoulos; J R Sanes
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

View more
  52 in total

1.  The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.

Authors:  Tohru Tezuka; Akane Inoue; Taisuke Hoshi; Scott D Weatherbee; Robert W Burgess; Ryo Ueta; Yuji Yamanashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 2.  Wnt signaling in neuromuscular junction development.

Authors:  Kate Koles; Vivian Budnik
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06       Impact factor: 10.005

3.  Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.

Authors:  Peter T Hallock; Chong-Feng Xu; Tae-Ju Park; Thomas A Neubert; Tom Curran; Steven J Burden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

4.  Muscle Yap Is a Regulator of Neuromuscular Junction Formation and Regeneration.

Authors:  Kai Zhao; Chengyong Shen; Yisheng Lu; Zhihui Huang; Lei Li; Christopher D Rand; Jinxiu Pan; Xiang-Dong Sun; Zhibing Tan; Hongsheng Wang; Guanglin Xing; Yu Cao; Guoqing Hu; Jiliang Zhou; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2017-02-17       Impact factor: 6.167

Review 5.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

6.  Regulation of chandelier cell cartridge and bouton development via DOCK7-mediated ErbB4 activation.

Authors:  Yilin Tai; Justyna A Janas; Chia-Lin Wang; Linda Van Aelst
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

7.  Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.

Authors:  Nazanin Ghazanfari; Marco Morsch; Stephen W Reddel; Simon X Liang; William D Phillips
Journal:  J Physiol       Date:  2014-05-23       Impact factor: 5.182

8.  AAV9-DOK7 gene therapy reduces disease severity in Smn2B/- SMA model mice.

Authors:  Kevin A Kaifer; Eric Villalón; Caley E Smith; Madeline E Simon; Jose Marquez; Abigail E Hopkins; Toni I Morcos; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2020-07-30       Impact factor: 3.575

Review 9.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

Review 10.  Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.

Authors:  Melany J Wagner; Melissa M Stacey; Bernard A Liu; Tony Pawson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.